查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1190615

一次性醫療器械傳感器市場 - 增長、趨勢、COVID-19 影響和預測 (2023-2028)

Disposable Medical Devices Sensors Market - Growth, Trends, and Forecasts (2023 - 2028)
出版日期: | 出版商: Mordor Intelligence | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

在 2022 年至 2027 年的預測期內，一次性醫療設備傳感器市場預計將以 10.8% 的複合年增長率增長。

COVID-19 的爆發增加了全球對一次性醫療設備傳感器的需求。 這主要是由於 COVID-19 病毒的高毒力導致醫療機構加強了感染控制措施。 公眾對更快獲得測試結果的簡便方法的認識不斷提高，這也促進了需求的增長。 為了方便和安全，消費者越來越多地選擇遠程醫療機構。 世界各地的研究人員都在爭先恐後地開發新方法，使用準確高效的生物傳感器在 SARS-CoV-2 大流行期間進行早期檢測。 例如，2020 年 4 月，加拿大衛生部將 Dexcom G6 連續血糖監測傳感器系統整合到醫療設備中，以便在應對 COVID-19 大流行的情況下擴展使用。 Dexcom G6傳感器的加拿大醫療器械許可證規定，它只能佩戴在一般成年人的腹部（肚皮）上。 因此，預計 COVID-19 流行期間對一次性醫療器械的需求增加將對市場產生積極影響。

一次性醫療設備傳感器市場受醫療成本上升、政府對研發活動的資助以及新興經濟體對傳感器技術的接受等因素推動。 例如，根據歐盟統計局 2021 年 12 月發布的數據，德國和法國在 2019 年的當前醫療保健支出佔 GDP 的比重最高。 德國目前的醫療支出水平在 2019 年達到 4030 億歐元，仍然是歐盟 (EU) 成員國中最高的。 德國和法國目前的醫療保健支出分別佔國內生產總值 (GDP) 的 11.7% 和 11.1%，高於任何其他歐盟成員國。 其次是瑞典（10.9%）、比利時（10.7%）、奧地利（10.4%）、荷蘭（10.2%）和丹麥（10.0%），其餘歐盟成員國均未達到兩位數百分比。 因此，不斷上漲的醫療保健成本支持了預測期內的市場增長。

根據發表在 IEE 期刊上的題為“Biosensors and Chemical Sensors for Healthcare Monitoring, A Review”的論文，歐盟成員國的醫療支出正在上升，支撐了預測期內的市場增長。 根據 2022 年 3 月在 IEEJ 電氣和電子工程彙刊上發表的“評論”，將生物傳感器和設備用於醫療診斷和預防目的至關重要。 在發達國家，需要可以在日常生活中使用的醫療設備（特別是用於檢測、診斷和傳感），以遏制與生活方式相關的疾病的增加和嚴重程度。 可穿戴生化設備是重要的個人設備，將發揮主導作用。 診斷設備現在在醫學上用於疾病預防和健康管理。 也應該可以抑制醫療和護理費用的上漲。 因此，生物傳感器在一次性醫療設備中的上述優勢有望在預測期內推動市場增長。

因此，考慮到上述因素，一次性醫療設備傳感器市場有望在預測期內得到推動。 然而，嚴格的監管環境和對新診斷技術缺乏認識阻礙了市場增長。

主要市場趨勢

患者監護預計在預測期內快速增長

患者監護是增長最快的市場之一，一次性傳感器廣泛用於患者監護。 在發展中國家的城市和農村地區，對家庭患者監測的需求不斷增長。 這種不斷增長的需求使公司能夠大量使用醫療設備傳感器來監測患者。

遠程患者監控允許醫生和醫院在傳統醫生辦公室之外監控患者，該技術可以在患者和醫生之間提供 24/7 數據。 根據 2021 年版的醫療保險和醫療補助服務中心，患者監護儀每年都會幫助數十萬高危患者避免再次入院並在家中過上更健康的生活。 使用遠程監控的客戶報告說再入院率降低了 76%，平均患者滿意度為 89%，並節省了大約 3.7 億美元的總醫療費用。

不僅在日本，在世界各地也有許多公司在處理用於患者監護的一次性傳感器。 提供這些傳感器的知名公司包括 Smiths Medical 和 Mediaid。 此外，2020 年 5 月，持續健康監測和臨床情報公司 BioIntelliSense, Inc. 通過推出 BioButton 設備，推進了其醫療級生物傳感器產品組合和數據即服務 (DaaS) 平台。 生物按鈕是一種硬幣大小的一次性醫療設備，可以連續測量體溫和其他生命體徵 90 天。 Biotellisense 是一種醫療級數據服務，它使用專有的生物傳感器技術和高級分析來實現有害趨勢的早期檢測，而成本僅為溫度測量和傳統遠程患者監測 (RPM) 系統的一小部分。

這表明傳感器在醫療設備中的使用有所增加，這將對預測期內研究的市場產生直接的積極影響。

北美在市場上占主導地位，預計在預測期內也會如此。

隨著創新傳感器開發技術的進步、基於傳感器的設備在該地區的廣泛採用以及不斷上升的醫療保健成本成為該地區市場增長的主要驅動力，預計北美將主導該市場。. 由於所研究的市場中存在主要參與者，美國擁有最大的市場份額。

根據醫療保險和醫療補助服務中心 2021 年 12 月的數據，2019-28 年全國醫療保健支出預計將以年均 5.4% 的速度增長，到 2028 年將達到 6.2 萬億美元。 預計 2019-28 年全國衛生支出年均增長速度將比國內生產總值快 1.1 個百分點，因此衛生支出在經濟中的份額預計將從 2018 年的 17.7% 上升到 2028 年的 19.7%。

此外，風險投資公司增加了對新型一次性醫療設備傳感器開發的投資。 例如，2022 年 5 月，Nemaura Medical, Inc. 是一家專注於將日常一次性可穿戴葡萄糖傳感器商業化並支持個性化數字教練計劃的醫療技術公司，宣布了一項沒有認股權證或可轉換元素的清潔債務融資。據報導，它已獲得 500 萬美元的非稀釋資金。

此外，主要市場參與者增加產品發布將進一步推動預測期內的市場增長。 例如，2020 年 7 月，生物傳感器技術先驅 ivWatch, LLC 的新型 SmartTouchTM 一次性傳感器獲得了美國食品藥品監督管理局 (FDA) 的許可，用於早期檢測外周靜脈浸潤和外滲事件。 此次 FDA 批准擴大了 ivWatch 傳感器產品組合，為醫院、輸液中心和其他醫療機構提供互補的傳感器解決方案，有助於提高患者安全並降低與輸液治療相關的風險。

因此，上述所有因素都有望在預測期內推動市場增長。

競爭格局

這個市場的競爭很低，大多數本地公司都在內部競爭。 然而，大部分市場份額被全球公司佔據。 在印度和南非等新興國家，當地公司正以較低的產品價格展開激烈競爭。 相信在不久的將來，這類中小企業將獲得很大的份額。 主要公司包括 Honeywell International, Inc.、Medtronic plc、Koninklijke Philips N.V.、Sensirion AG 和 Smiths Medical。

其他好處

  • Excel 格式的市場預測 (ME) 表
  • 三個月的分析師支持

內容

第1章介紹

  • 研究假設和市場定義
  • 調查範圍

第2章 調查手法

第 3 章執行摘要

第4章市場動態

  • 市場概覽
  • 市場驅動因素
    • 與醫療保健相關的支出增加
    • 鼓勵風險投資公司投資開發新型一次性醫療設備傳感器
    • 傳感器技術的進步和接受度的快速提高
  • 市場製約因素
    • 嚴格的監管場景
    • 缺乏對新診斷技術的認識
  • 波特的五力分析
    • 新進入者的威脅
    • 買方/消費者議價能力
    • 供應商的議價能力
    • 替代品的威脅
    • 競爭公司之間的敵對關係

第 5 章市場細分（基於價值的市場規模 - 百萬美元）

  • 按產品分類
    • 生物傳感器
    • 圖像傳感器
    • 加速度計
    • 溫度傳感器
    • 其他
  • 通過申請
    • 病人監護
    • 診斷
    • 治療藥物
  • 按地區
    • 北美
      • 美國
      • 加拿大
      • 墨西哥
    • 歐洲
      • 德國
      • 英國
      • 法國
      • 意大利
      • 西班牙
      • 其他歐洲地區
    • 亞太地區
      • 中國
      • 日本
      • 印度
      • 澳大利亞
      • 韓國
      • 其他亞太地區
    • 中東和非洲
      • 海灣合作委員會
      • 南非
      • 其他中東和非洲地區
    • 南美洲地區
      • 巴西
      • 阿根廷
      • 其他南美洲

第6章競爭格局

  • 公司簡介
    • NXP Semiconductors（Freescale Semiconductor, Inc.）
    • GE Healthcare
    • Gentag Inc.
    • Honeywell International, Inc.
    • Medtronic plc
    • Koninklijke Philips N.V.
    • Sensirion AG
    • Medical Sensors India Pvt. Ltd
    • Shenzhen Med-Link Electronics Tech Co., Ltd.
    • Starboard Medical, Inc.
    • Smiths Medical
    • Nuova GmbH

第7章 市場機會與今後動向

簡介目錄
Product Code: 49953

Disposable Medical Devices Sensors Market is poised to grow at a CAGR of 10.8% during the forecast period, 2022-2027.

The global demand for disposable medical device sensors has increased as a result of the COVID-19 outbreak. This is primarily due to increased infection control measures in healthcare settings as a result of the COVID-19 virus's high virulence. People's growing awareness of simple and convenient ways to obtain faster test results also contributes to the rising demand. Consumers are increasingly choosing remote healthcare facilities for the convenience and security of their own homes. Researchers around the world have been rushing to develop accurate and efficient novel biosensor-based approaches for the early detection of SARS-CoV-2 during the current pandemic. For Instance, in April 2020, Health Canada has included the Dexcom G6 Continuous Glucose Monitoring Sensor System in medical devices for expanded use in relation to the COVID-19 pandemic. The Dexcom G6 Sensor's Canadian Medical Device Licence specifies that it be worn on the abdomen in the general adult population (belly). Thus, during the COVID-19 the demand for the disposable medical devices increased thereby expected to show positive impact on the market.

The Disposable Medical Devices Sensors market is being driven by factors such as increasing healthcare expenditure, government provisions for R&D activities, and acceptance of the sensor technology in the developing economies. For instance, according to Eurostat data published in December 2021, Germany and France had the highest current healthcare expenditure relative to GDP in 2019. The level of current healthcare expenditure in Germany was EUR 403 billion in 2019 and remains at the highest level among the European Union (EU) Member States. Current healthcare expenditure in Germany and France was equivalent to 11.7 % and 11.1 %, respectively, of gross domestic product (GDP), more than in any other EU Member State. The next highest ratios were in Sweden (10.9 %), Belgium (10.7 %), Austria (10.4 %), the Netherlands (10.2 %) and Denmark (10.0 %); none of the remaining EU Member States recorded double-digit ratios. Thus, increasing healthcare expenditure supports the market growth over the forecast period.

According to the study titled "Biosensors and Chemical Sensors for Healthcare Monitoring: A Review" published in the IEEJ Transactions on Electrical and Electronic Engineering in March 2022, It has been a top priority to use biosensors and equipment for medical diagnostic and preventive purposes. In order to control the rise in lifestyle-related diseases and their severity, developed countries need medical devices that can be used in daily life (especially for testing, diagnosis, and sensing). Wearable biological and chemical devices are significant personal devices that will be a key player in this process. Diagnostic devices are currently used in medicine for disease prevention and health management. They should also keep the costs of medical and nursing care from rising. Thus, due to the above benefits of the disposable medical devices biosensor anticipated to drive the growth of the market over the forecast period.

Thus, given the aforementioned factors, the disposable medical devices sensor market is anticipated to propel over the forecast period. However, stringent regulatory scenario and lack of awareness of new diagnostics technologies restraint the market growth.

Key Market Trends

Patient Monitoring is Expected to Show Rapid Growth Over the Forecast Period

Patient monitoring is one of the rapidly growing markets and disposable sensors are widely being used for patient monitoring. In the rural as well as urban areas of developing countries, there is a growing demand for in-home patient monitoring. This rising demand is allowing the companies to utilize medical device sensors largely for patient monitoring.

Remote patient monitoring allows physicians and hospitals to monitor patients outside of the conventional clinic setting, where the technology can provide 24/7 data between patients and physicians. According to the center of Medicare and Medicaid Services 2021, every year, patient monitors help hundreds of thousands of high-risk patients avoid being readmitted to the hospital and make the most of their healthy days at home. Clients who use remote monitoring report a 76% reduction in readmission rates, an average of 89 % patient satisfaction, and a total medical cost savings of nearly USD 370 million.​

There is a large number of local as well as global companies that are into the disposable sensors for patient monitoring. Some of the well-known players providing these sensors include Smiths Medical, Mediaid, Inc., etc. Additionally, in May 2020, BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, reported the advancement of its medical-grade biosensor product portfolio and Data-as-a-Service (DaaS) platform with the introduction of the BioButton device. The BioButton is a coin-sized, disposable medical device that measures continuous temperature and other vital signs for a remarkable 90-days. BioIntelliSense offers medical-grade data services that allow for early detection of adverse trends through its proprietary biosensor technology and advanced analytics at a fraction of the cost of spot temperature measurements or traditional Remote Patient Monitoring (RPM) systems.

This indicates the rising use of medical device sensors which will directly affect the market studied in a positive manner over the forecast period.

North America Dominates the Market and Expected to do Same in the Forecast Period.

North America is expected to dominate the market and the major factors attributed to the growth of the market in the region are a technological advancement in innovative sensors development and the high adoption rate of sensors-based devices in the region, rising healthcare spending. United States holds the largest market share due to the presence of key players in the market studied.

According to the Centers for Medicare & Medicaid Services in December 2021, the National health spending is projected to grow at an average annual rate of 5.4% for 2019-28 and to reach USD 6.2 trillion by 2028. As national health expenditures are projected to grow 1.1 percentage points faster than gross domestic product per year on average over 2019-28, the health share of the economy is projected to rise from 17.7% in 2018 to 19.7% in 2028.

Moreover, enhanced investments by venture capital firms to develop novel disposable medical device sensors. For instance, in May 2022, Nemaura Medical, Inc. a medical technology company focused on commercializing a daily disposable wearable glucose sensor and supporting personalized digital coaching programs, reported that it has secured USD 5 million in non-dilutive funding though a clean debt facility with no warrants or convertible elements.

In addition, increasing product launches by the key market player further expand the market growth over the projecting period. For instance, in July 2020, ivWatch, LLC, a pioneer in biosensor technology, has received Food and Drug Administration (FDA) clearance for its new SmartTouchTM disposable sensor for the early detection of peripheral IV infiltration and extravasation events. This new FDA clearance expands the ivWatch sensor portfolio to provide hospitals, infusion centers, and other healthcare facilities with complementary sensor solutions to help improve patient safety and reduce the risks associated with IV therapy.

Thus, all aforementioned factors anticipated to boost the market growth over the forecast period.

Competitive Landscape

The market studied is moderately competitive and most of the local companies are having internal competition among themselves. The larget market share, however, is gained by global companies. In developing countries such as India, South Africa, etc., the local companies are posing intense competition due to the low prices of the products. In the near future, such small to mid-sized companies are believed to gain a substantial share of the market. Some of the key players are Honeywell International, Inc., Medtronic plc, Koninklijke Philips N.V., Sensirion AG, Smiths Medical

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Increasing Healthcare Expenditure
    • 4.2.2 Enhanced Investments by Venture Capital Firms to Develop Novel Disposable Medical Devices Sensors
    • 4.2.3 Rapid Increase in Advancement an Acceptance of Sensor Technology
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Scenario
    • 4.3.2 Lack of Awareness in New Diagnostics Technologies
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION (Market Size by Value - USD Million)

  • 5.1 By Product
    • 5.1.1 Biosensor
    • 5.1.2 Image Sensor
    • 5.1.3 Accelerometer
    • 5.1.4 Temperature Sensors
    • 5.1.5 Others
  • 5.2 By Application
    • 5.2.1 Patient Monitoring
    • 5.2.2 Diagnostics
    • 5.2.3 Therapeutics
  • 5.3 Geography
    • 5.3.1 North America
      • 5.3.1.1 United States
      • 5.3.1.2 Canada
      • 5.3.1.3 Mexico
    • 5.3.2 Europe
      • 5.3.2.1 Germany
      • 5.3.2.2 United Kingdom
      • 5.3.2.3 France
      • 5.3.2.4 Italy
      • 5.3.2.5 Spain
      • 5.3.2.6 Rest of Europe
    • 5.3.3 Asia-Pacific
      • 5.3.3.1 China
      • 5.3.3.2 Japan
      • 5.3.3.3 India
      • 5.3.3.4 Australia
      • 5.3.3.5 South Korea
      • 5.3.3.6 Rest of Asia-Pacific
    • 5.3.4 Middle-East and Africa
      • 5.3.4.1 GCC
      • 5.3.4.2 South Africa
      • 5.3.4.3 Rest of Middle-East and Africa
    • 5.3.5 South America
      • 5.3.5.1 Brazil
      • 5.3.5.2 Argentina
      • 5.3.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 NXP Semiconductors (Freescale Semiconductor, Inc.)
    • 6.1.2 GE Healthcare
    • 6.1.3 Gentag Inc.
    • 6.1.4 Honeywell International, Inc.
    • 6.1.5 Medtronic plc
    • 6.1.6 Koninklijke Philips N.V.
    • 6.1.7 Sensirion AG
    • 6.1.8 Medical Sensors India Pvt. Ltd
    • 6.1.9 Shenzhen Med-Link Electronics Tech Co., Ltd.
    • 6.1.10 Starboard Medical, Inc.
    • 6.1.11 Smiths Medical
    • 6.1.12 Nuova GmbH

7 MARKET OPPORTUNITIES AND FUTURE TRENDS